GSK-3484862 targets DNMT1 for degradation in cells
Q. Chen, Y. Zeng, J. W. Hwang…·X. Cheng
This paper shows that GSK-3484862 targets DNMT1 for degradation in cancer cells and mouse embryonic stem cells, leading to DNA hypomethylation without reducing DNMT1 mRNA levels.